MRD / Regn No. : 20260000237 Date : 08/06/2026
Patient Name : Gopa Bose Age & Gender : 45 Yrs. / Female
Contact No. : 9051831031 UHID :
Ht / Wt / BMI : 152 / 62 / 26.84 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (06/Apr/2022) | HYPOTHYROIDISM (06/Apr/2026) | OBESITY (06/Apr/2026) | MASLD (06/Apr/2026) |
Subjective : TYPE 2 DM,HYPOTHYROIDISM,2 KG WEIGHT GAIN,MENOPAUSE 2009
Objective : NONE
Analysis : TYPE 2 DM,HYPOTHYROIDISM,OBESITY,INCREASED FIB4 SCCORE,S2F0 MASLD
Plan : INCREASE SEMAGLUTIDE TO 1 MG,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 180 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 197 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET THYROXINE 100 MCG
THYRONORM 100 MCG
Medicine For LOW THYROID 		PO 1-0-0 EMPTY STOMACH
 TILL NEXT VISIT
MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR B...
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 INJECTION SEMAGLUTIDE 1 MG
OZEMPIC
Medicine For OBESITY DIABETES 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
 TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING
       
Refill : 0 / Substitution:    
Education :
Next Visit : 07/Aug/2026
Tests Suggested For Next Visit : HBA1C FBS 2HPP,FREE T4 TSH
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: